pyridoxamine has been researched along with pyruvaldehyde in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (33.33) | 29.6817 |
| 2010's | 7 (46.67) | 24.3611 |
| 2020's | 3 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biemel, KM; Lederer, MO; Mally, A; Nagaraj, RH; Padayatti, PS; Sarkar, P | 1 |
| Chetyrkin, SV; Chuang, P; Ham, AJ; Hudson, BG; Mathieson, PW; Pedchenko, VK; Saleem, MA; Voziyan, PA | 1 |
| Nagaraj, RH; Padival, S | 1 |
| Ahmad, MS; Ahmed, N; Pischetsrieder, M | 1 |
| Barter, PJ; Brown, BE; Davies, MJ; Nobécourt, E; Rye, KA; Yadav, S; Zeng, J | 1 |
| Kim, CS; Kim, J; Kim, JS; Kim, NH; Sohn, E | 1 |
| Brownstein, S; Milne, R | 1 |
| Almeida, F; Crisóstomo, J; Gonçalves, L; Matafome, P; Rodrigues, T; Santos-Silva, D; Seiça, R; Sena, C | 1 |
| Cardoso, S; Carvalho, C; Marinho, R; Matafome, P; Moreira, PI; Santos, MS; Seiça, RM; Sena, CM; Simões, A | 1 |
| Amarnath, K; Amarnath, V; Avance, J; Stec, DF; Voziyan, P | 1 |
| Aldini, G; Carini, M; Casali, G; Colzani, M; De Maddis, D; Vistoli, G | 1 |
| Hendriks, JJA; Miyata, T; Schalkwijk, CG; Scheijen, JLJM; Vanmierlo, T; Wetzels, S; Wouters, K | 1 |
| Bao, X; Huang, Y; Lai, K; Miao, J | 1 |
| Dong, J; Guan, H; Jiang, M; Liu, Y; Lu, S; Niu, Y; Song, F; Tang, J; Tian, M; Yakupu, A | 1 |
| Eussen, SJMP; Hanssen, NMJ; Houben, AJHM; Kusters, YHAM; Linkens, AMA; Miyata, T; Niessen, PM; Schalkwijk, CG; Scheijen, JLJM; Simons, N; Stehouwer, CDA; Van den Eynde, MDG | 1 |
1 review(s) available for pyridoxamine and pyruvaldehyde
| Article | Year |
|---|---|
Advanced glycation end products and diabetic retinopathy.
Topics: Animals; Blood-Retinal Barrier; Diabetic Retinopathy; Glycation End Products, Advanced; Molecular Targeted Therapy; Neovascularization, Pathologic; Pericytes; Pyridoxamine; Pyruvaldehyde; Retina; Signal Transduction | 2013 |
1 trial(s) available for pyridoxamine and pyruvaldehyde
| Article | Year |
|---|---|
Pyridoxamine reduces methylglyoxal and markers of glycation and endothelial dysfunction, but does not improve insulin sensitivity or vascular function in abdominally obese individuals: A randomized double-blind placebo-controlled trial.
Topics: Female; Glycation End Products, Advanced; Humans; Insulin Resistance; Magnesium Oxide; Maillard Reaction; Male; Middle Aged; Obesity; Pyridoxamine; Pyruvaldehyde | 2023 |
13 other study(ies) available for pyridoxamine and pyruvaldehyde
| Article | Year |
|---|---|
Effect of pyridoxamine on chemical modification of proteins by carbonyls in diabetic rats: characterization of a major product from the reaction of pyridoxamine and methylglyoxal.
Topics: Animals; Arginine; Cattle; Chromatography, High Pressure Liquid; Crystallins; Diabetes Mellitus, Experimental; Dimerization; Erythrocytes; Glutathione; Glycation End Products, Advanced; Lactoylglutathione Lyase; Lysine; Magnetic Resonance Spectroscopy; Maillard Reaction; Models, Chemical; Oxidative Stress; Pyridoxamine; Pyruvaldehyde; Rats; Rats, Sprague-Dawley; Thiobarbituric Acid Reactive Substances | 2002 |
Mechanism of perturbation of integrin-mediated cell-matrix interactions by reactive carbonyl compounds and its implication for pathogenesis of diabetic nephropathy.
Topics: Aldehydes; Arginine; Binding Sites; Cell Adhesion; Cell Physiological Phenomena; Collagen Type IV; Diabetic Nephropathies; Endothelial Cells; Extracellular Matrix; Extracellular Matrix Proteins; Glucose; Glyoxal; Humans; Integrin alphaVbeta3; Integrins; Kidney; Kidney Glomerulus; Pyridoxamine; Pyruvaldehyde; Umbilical Veins | 2005 |
Pyridoxamine inhibits maillard reactions in diabetic rat lenses.
Topics: Aldehyde Reductase; Animals; Arginine; Chromatography, High Pressure Liquid; Diabetes Complications; Diabetes Mellitus, Experimental; Glucose; Glutathione; Glycation End Products, Advanced; Lactoylglutathione Lyase; Lens Diseases; Lens, Crystalline; Lysine; Maillard Reaction; Male; Organ Culture Techniques; Ornithine; Pyridoxamine; Pyrimidines; Pyruvaldehyde; Rats; Rats, Sprague-Dawley | 2006 |
Aged garlic extract and S-allyl cysteine prevent formation of advanced glycation endproducts.
Topics: Aging; Antioxidants; Cysteine; Diabetes Complications; Electrophoresis, Polyacrylamide Gel; Free Radicals; Garlic; Glucose; Glycation End Products, Advanced; Humans; Hyperglycemia; Muramidase; Peptide Fragments; Plant Extracts; Pyridoxamine; Pyruvaldehyde; Ribose | 2007 |
Effects of cross-link breakers, glycation inhibitors and insulin sensitisers on HDL function and the non-enzymatic glycation of apolipoprotein A-I.
Topics: Apolipoprotein A-I; Arginine; Cross-Linking Reagents; Glycosylation; Guanidines; Humans; Lipoproteins, HDL; Lysine; Metformin; Phosphatidylcholine-Sterol O-Acyltransferase; Pyridoxamine; Pyruvaldehyde; Thiazoles; Tryptophan | 2008 |
Methylglyoxal induces cellular damage by increasing argpyrimidine accumulation and oxidative DNA damage in human lens epithelial cells.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Apoptosis; Caspase 3; Cell Line; Deoxyguanosine; DNA Damage; Epithelial Cells; Glycation End Products, Advanced; Humans; Lens, Crystalline; Ornithine; Oxidative Stress; Pyridoxamine; Pyrimidines; Pyruvaldehyde | 2010 |
Pyridoxamine reverts methylglyoxal-induced impairment of survival pathways during heart ischemia.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Cell Survival; Glycation End Products, Advanced; JNK Mitogen-Activated Protein Kinases; Myocardial Ischemia; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Pyridoxamine; Pyruvaldehyde; Rats; Rats, Wistar | 2013 |
Effects of methylglyoxal and pyridoxamine in rat brain mitochondria bioenergetics and oxidative status.
Topics: Animals; Brain; Energy Metabolism; Glycation End Products, Advanced; Glyoxal; Male; Mitochondria; Oxidation-Reduction; Oxidative Stress; Oxygen Consumption; Pyridoxamine; Pyruvaldehyde; Random Allocation; Rats; Rats, Wistar | 2014 |
5'-O-Alkylpyridoxamines: Lipophilic Analogues of Pyridoxamine Are Potent Scavengers of 1,2-Dicarbonyls.
Topics: Biocatalysis; Electron Spin Resonance Spectroscopy; Free Radical Scavengers; Free Radicals; Glucose; Horseradish Peroxidase; Hydrophobic and Hydrophilic Interactions; Membrane Proteins; Molecular Conformation; Muramidase; Pyridoxamine; Pyruvaldehyde; Spectrophotometry, Ultraviolet; Superoxide Dismutase | 2015 |
Reactivity, Selectivity, and Reaction Mechanisms of Aminoguanidine, Hydralazine, Pyridoxamine, and Carnosine as Sequestering Agents of Reactive Carbonyl Species: A Comparative Study.
Topics: Aldehydes; Carnosine; Dose-Response Relationship, Drug; Glyoxal; Guanidines; Humans; Hydralazine; Malondialdehyde; Molecular Structure; Pyridoxamine; Pyruvaldehyde; Sequestering Agents; Structure-Activity Relationship | 2016 |
Advanced Glycation Endproducts Are Increased in the Animal Model of Multiple Sclerosis but Cannot Be Reduced by Pyridoxamine Treatment or Glyoxalase 1 Overexpression.
Topics: Animals; Brain; Encephalomyelitis, Autoimmune, Experimental; Female; Glycation End Products, Advanced; Glycolysis; Humans; Lactoylglutathione Lyase; Mice; Mice, Inbred C57BL; Pyridoxamine; Pyruvaldehyde; Spinal Cord; Vitamin B Complex | 2018 |
Revealing a key inhibitory mechanism of 2-amino-3,8-dimethylimidazo[4,5-f] quinoxaline via trapping of methylglyoxal.
Topics: Amines; Animals; Cooking; Fish Products; Hot Temperature; Hydroxybenzoates; Mutagens; Pyridoxamine; Pyruvaldehyde; Quinoxalines; Tilapia; Vitamins | 2020 |
Pyridoxamine ameliorates methylglyoxal-induced macrophage dysfunction to facilitate tissue repair in diabetic wounds.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Macrophages; Mice; Pyridoxamine; Pyruvaldehyde; Wound Healing | 2022 |